Evotec AG (EVT.F)


Frankfurt - Frankfurt Delayed Price. Currency in EUR
4.95+0.05 (+1.12%)
As of 5:16 AM EDT. Market open.
People also watch:
MOR.FEVT.DEIFX.FSNG.FPA8.F
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open4.86
Prev Close4.90
Bid4.96 x 400000
Ask4.96 x 400000
Day's Range4.86 - 4.95
52wk Range2.87 - 4.96
1y Target EstN/A
Market Cap650.2M
P/E Ratio (ttm)127.05
BetaN/A
Volume12,274
Avg Vol (3m)22,199
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Business Wire6 hours ago

    Evotec Enters into Strategic Multi-Target Alliance with C4X Discovery

    Evotec AG today announced a multi-target collaboration with C4X Discovery Holdings plc . The new agreement builds on the successful research collaboration with C4XD announced in January 2015 and will see C4XD and Evotec work together to develop new small molecule drugs across a range of targets, therapeutic areas and stages of development, with the initial programmes targeted towards the treatment ...

  • Business Wire6 days ago

    Evotec Enters into a Research Collaboration with Inserm in Oncology

    Evotec AG announced today that the Company has entered into a research collaboration with Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research .

  • Business Wire16 days ago

    Evotec to Attend Two Upcoming Investor Conferences

    Evotec AG announced today that its CEO, Dr Werner Lanthaler, will be presenting at the 5th German Corporate Conference, Berenberg/Goldman Sachs and will be attending Baader Investment Conference.